TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $2.61 billion. The enterprise value is $2.99 billion.
| Market Cap | 2.61B |
| Enterprise Value | 2.99B |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026, after market close.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.56 million shares outstanding. The number of shares has increased by 8.45% in one year.
| Current Share Class | 34.56M |
| Shares Outstanding | 34.56M |
| Shares Change (YoY) | +8.45% |
| Shares Change (QoQ) | -11.57% |
| Owned by Insiders (%) | 3.22% |
| Owned by Institutions (%) | 107.47% |
| Float | 33.44M |
Valuation Ratios
The trailing PE ratio is 16.91 and the forward PE ratio is 33.00.
| PE Ratio | 16.91 |
| Forward PE | 33.00 |
| PS Ratio | 4.08 |
| Forward PS | 3.39 |
| PB Ratio | 5.10 |
| P/TBV Ratio | 5.37 |
| P/FCF Ratio | 17.12 |
| P/OCF Ratio | 11.77 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.88, with an EV/FCF ratio of 19.77.
| EV / Earnings | 17.41 |
| EV / Sales | 4.71 |
| EV / EBITDA | 23.88 |
| EV / EBIT | 31.69 |
| EV / FCF | 19.77 |
Financial Position
The company has a current ratio of 6.74, with a Debt / Equity ratio of 1.75.
| Current Ratio | 6.74 |
| Quick Ratio | 6.01 |
| Debt / Equity | 1.75 |
| Debt / EBITDA | 6.47 |
| Debt / FCF | 5.70 |
| Interest Coverage | 5.40 |
Financial Efficiency
Return on equity (ROE) is 45.22% and return on invested capital (ROIC) is 13.49%.
| Return on Equity (ROE) | 45.22% |
| Return on Assets (ROA) | 5.19% |
| Return on Invested Capital (ROIC) | 13.49% |
| Return on Capital Employed (ROCE) | 7.03% |
| Weighted Average Cost of Capital (WACC) | 11.34% |
| Revenue Per Employee | $708,118 |
| Profits Per Employee | $191,452 |
| Employee Count | 898 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 5.11 |
Taxes
| Income Tax | -82.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.17% in the last 52 weeks. The beta is 1.88, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | -47.17% |
| 50-Day Moving Average | 86.25 |
| 200-Day Moving Average | 115.62 |
| Relative Strength Index (RSI) | 50.50 |
| Average Volume (20 Days) | 1,220,745 |
Short Selling Information
The latest short interest is 7.36 million, so 21.29% of the outstanding shares have been sold short.
| Short Interest | 7.36M |
| Short Previous Month | 8.18M |
| Short % of Shares Out | 21.29% |
| Short % of Float | 22.00% |
| Short Ratio (days to cover) | 3.88 |
Income Statement
In the last 12 months, TMDX had revenue of $635.89 million and earned $171.92 million in profits. Earnings per share was $4.46.
| Revenue | 635.89M |
| Gross Profit | 375.74M |
| Operating Income | 94.44M |
| Pretax Income | 89.33M |
| Net Income | 171.92M |
| EBITDA | 125.35M |
| EBIT | 94.44M |
| Earnings Per Share (EPS) | $4.46 |
Balance Sheet
The company has $461.74 million in cash and $863.42 million in debt, with a net cash position of -$401.68 million or -$11.62 per share.
| Cash & Cash Equivalents | 461.74M |
| Total Debt | 863.42M |
| Net Cash | -401.68M |
| Net Cash Per Share | -$11.62 |
| Equity (Book Value) | 494.01M |
| Book Value Per Share | 14.30 |
| Working Capital | 527.36M |
Cash Flow
In the last 12 months, operating cash flow was $220.23 million and capital expenditures -$68.87 million, giving a free cash flow of $151.36 million.
| Operating Cash Flow | 220.23M |
| Capital Expenditures | -68.87M |
| Depreciation & Amortization | 30.91M |
| Net Borrowing | n/a |
| Free Cash Flow | 151.36M |
| FCF Per Share | $4.38 |
Margins
Gross margin is 59.09%, with operating and profit margins of 14.85% and 27.04%.
| Gross Margin | 59.09% |
| Operating Margin | 14.85% |
| Pretax Margin | 14.05% |
| Profit Margin | 27.04% |
| EBITDA Margin | 19.71% |
| EBIT Margin | 14.85% |
| FCF Margin | 23.80% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.45% |
| Shareholder Yield | -8.45% |
| Earnings Yield | 6.63% |
| FCF Yield | 5.84% |
Analyst Forecast
The average price target for TMDX is $116.78, which is 54.72% higher than the current price. The consensus rating is "Buy".
| Price Target | $116.78 |
| Price Target Difference | 54.72% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 18.48% |
| EPS Growth Forecast (3Y) | 20.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 3.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.46 |
| Piotroski F-Score | 5 |